
Sign up to save your podcasts
Or


EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.
By cancerGRACE - H. Jack West, MDEGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.

2 Listeners

1 Listeners
0 Listeners
0 Listeners
1 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners